Diclofenac

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Widespread NSAID (non-steroidal antiinflammatory drug) with pronounced analgesic, antipyretic, antiphlogistic opioid-sparing effect. Also possible as an analgesic booster to paracetamol or metamizole (balanced analgesia).

IndicationThis section has been translated automatically.

  • Inflammation, painful swelling, rheumatoid arthritis, arthrosis.
  • Since increased COX 2 levels in carcinoma in situ, type "actinic keratosis" can be detected (also in spinocellular carcinomas), a 3% local therapeutic agent (diclofenac-hyaluronic acid gel) is successfully used for actinic keratoses.

Dosage and method of useThis section has been translated automatically.

2 times/day 50-150 mg p.o., i.m., i.v.

Undesirable effectsThis section has been translated automatically.

  • Systemic therapy: gastrointestinal ulcers, exanthema, photosensitivity.
  • With local application: redness, itching and rarely allergic contact reactions.

PreparationsThis section has been translated automatically.

  • Voltaren, Duravolten, Effekton, Diclofenac-ratiopharm
  • Solaraze (local therapeutic agent)

Note(s)This section has been translated automatically.

The combination of diclofenac with another mixed NSAID like ibuprofen/naproxen (inhibition of cyclooxygenases 1 and 2) or a selective COX-2 inhibitor like parecoxib is contraindicated.

LiteratureThis section has been translated automatically.

  1. Jage J (2009) Key questions on the therapy of postoperative pain. Georg Thieme Publishing House, Stuttgart S.16-21
  2. Merk HF (2007) Topical diclofenac in the treatment of actinic keratoses. Int J Dermatol 46: 8-12

Authors

Last updated on: 29.10.2020